FGF2 and Parkinson disease: In another study, Zhao et al., designed a new phospholipid-based gelatin NP to encapsulate bFGF against PD, and IN administration of this system showed obvious therapeutic effects (e.g., stimulation of the dopaminergic function in surviving neurons and partial conversion of the loss of dopaminergic neurons) in PD rats [91].